Alliancebernstein L.P. Sells 15,791 Shares of Option Care Health, Inc. $OPCH

Key Points

• Alliancebernstein L.P. decreased its holdings in Option Care Health by 2.7%, now owning approximately 570,908 shares valued at $19.95 million.
• Recent transactions by insiders, including substantial purchases by directors, have increased their ownership stake, indicating potential confidence in the company.
• Brokerages have given Option Care Health a "Moderate Buy" rating with an average price target of $35.75, reflecting positive growth forecasts.

Alliancebernstein L.P. trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 570,908 shares of the company's stock after selling 15,791 shares during the period. Alliancebernstein L.P. owned approximately 0.35% of Option Care Health worth $19,953,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Compass Wealth Management LLC lifted its holdings in shares of Option Care Health by 8.9% during the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after acquiring an additional 13,600 shares during the period. Bessemer Group Inc. raised its position in Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Option Care Health by 1.4% during the first quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after purchasing an additional 6,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Option Care Health by 25.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after purchasing an additional 1,691 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Option Care Health by 307.1% in the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock valued at $112,000 after purchasing an additional 2,408 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Trading Down 1.2%

NASDAQ OPCH traded down $0.33 during trading hours on Tuesday, reaching $27.56. The company's stock had a trading volume of 2,011,690 shares, compared to its average volume of 1,799,825. The firm has a fifty day simple moving average of $28.96 and a 200-day simple moving average of $31.35. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $4.47 billion, a P/E ratio of 22.05, a P/E/G ratio of 1.70 and a beta of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company's revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the acquisition, the director owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, Director Norman L. Wright bought 3,411 shares of Option Care Health stock in a transaction dated Tuesday, September 9th. The stock was purchased at an average price of $29.31 per share, with a total value of $99,976.41. Following the completion of the purchase, the director owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 59,411 shares of company stock worth $1,627,576 over the last three months. Company insiders own 0.64% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on OPCH. JMP Securities upped their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. Finally, Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.